Literature DB >> 5361015

Increased hepatic microsomal activity induced by spironolactone and other steroids.

B Solymoss, H G Classen, S Varga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5361015     DOI: 10.3181/00379727-132-34342

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  18 in total

1.  Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.

Authors:  H F VOHRINGER; L Weller; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Protection by spironolactone and different antidotes against acute organic mercury poisoning of rats.

Authors:  K Lehotzky
Journal:  Int Arch Arbeitsmed       Date:  1974

Review 3.  Protection by catatoxic steroids against cyclophosphamide-induced organ lesions.

Authors:  H Selye
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

4.  [Effect of spironolactone on the regeneration ability of the liver in rats].

Authors:  E Horvath; A Somogyi; K Kovacs
Journal:  Klin Wochenschr       Date:  1970-03-15

5.  Resistance to picrotoxin poisoning induced by catatoxic steroids.

Authors:  H Selye
Journal:  Agents Actions       Date:  1970-03

6.  [The effect of probenecid on the distribution of digitoxin, digoxin and ouabain in the mouse].

Authors:  K H Damm; W Braun; H Heckert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  On the catatoxic effect of antimineralocorticoids.

Authors:  H Selye; R Mandeville; E Yeghiayan
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

8.  Effect of stress on the adrenocorticolytic and carcinogenic action of 7,12-dimethylbenz(a)anthracene.

Authors:  A Somogyi; K Kovacs
Journal:  Z Krebsforsch       Date:  1971

9.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.

Authors:  M Davis; R Williams; J Chakraborty; J English; V Marks; G Ideo; S Tempini
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.